Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations

BMC Genomics

Volumn 12, Issue SUPPL. 4, 2011, Pages

  Cohen, Elisangela M L ^a   Machado, Karina S ^a   Cohen, Marcelo ^a   Norberto de Souza, Osmar ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL ENZYME; ENZYME INHIBITOR; ETHIONAMIDE; ISONIAZID DERIVATIVE; LIGAND; MUTANT PROTEIN; PENTACYANO(ISONIAZID)FERRATE II; PROTEIN; RECEPTOR; TRICLOSAN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; INHA PROTEIN, MYCOBACTERIUM; OXIDOREDUCTASE;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG DESIGN; EXPLICIT FLEXIBILITY; FULLY FLEXIBLE RECEPTOR MODEL; MODEL; MOLECULAR DOCKING; MYCOBACTERIUM TUBERCULOSIS; PROTEIN CONFORMATION; PROTEIN INTERACTION; RECEPTOR BINDING; SIMULATION; AUTOMATION; CHEMISTRY; CLUSTER ANALYSIS; COMPUTER PROGRAM; ENZYMOLOGY; GENETICS; INTERNET; METABOLISM; MOLECULAR DYNAMICS; MUTATION; PROTEIN TERTIARY STRUCTURE;

AUTOMATION; BACTERIAL PROTEINS; CLUSTER ANALYSIS; INTERNET; LIGANDS; MOLECULAR DYNAMICS SIMULATION; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; PROTEIN STRUCTURE, TERTIARY; SOFTWARE;

EID: 84255200942     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-S4-S7     Document Type: Article

References (35)

1. Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin TE. A geometric approach to macromolecule-ligand interactions. J. Mol. Biol 1982, 161(2):269-288. 10.1016/0022-2836(82)90153-X, 7154081.
2. Lengauer T, Rarey M. Computational methods for biomolecular docking. Curr. Opin. Struct. Biol 1996, 6(3):402-406. 10.1016/S0959-440X(96)80061-3, 8804827.
3. Koshland DE. Application of a theory of enzyme specificity to protein synthesis. Proc. Natl. Acad. Sci.USA 1958, 44(2):98-104. 10.1073/pnas.44.2.98, 335371, 16590179.
4. Koshland DE. The key-lock theory and the induced fit theory. Angew. Chem. Int. Ed. Eng 1995, 33(23 24):2375-2378.
5. Sotriffer CA, Flader W, Winger RH, Rode BM, Liedl KR, Varga JM. Automated docking of ligands to antibodies: methods and applications. Methods 2000, 20(3):280-291. 10.1006/meth.1999.0922, 10694451.
6. Cozzini P, Kellogg GE, Spyrakis F, Abraham DJ, Costantino G, Emerson A, Fanelli F, Gohlke H, Kuhn LA, Morris GM. Target Flexibility: An Emerging Consideration in Drug Discovery and Design†. J. Med. Chem 2008, 51(20):6237-6255. 10.1021/jm800562d, 2701403, 18785728.
7. Carlson HA, McCammon JA. Accommodating protein flexibility in computational drug design. Mol. Pharmacol 2000, 57(2):213.
8. Erickson JA, Jalaie M, Robertson DH, Lewis RA, Vieth M. Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy. J. Med. Chem 2004, 47(1):45-55. 10.1021/jm030209y, 14695819.
9. Cavasotto CN, Abagyan RA. Protein flexibility in ligand docking and virtual screening to protein kinases. J. Mol. Biol 2004, 337:209-225. 10.1016/j.jmb.2004.01.003, 15001363.
10. Totrov M, Abagyan R. Flexible ligand docking to multiple receptor conformations: a practical alternative. Curr. Opin. Struct. Biol 2008, 18(2):178-184. 10.1016/j.sbi.2008.01.004, 2396190, 18302984.
11. van Gunsteren WF, Berendsen HJC. Computer simulation of molecular dynamics: Methodology, applications, and perspectives in chemistry. Angew. Chem. Int. Ed. Eng 1990, 29(9):992-1023.
12. Lin JH, Perryman AL, Schames JR, McCammon JA. Computational drug design accommodating receptor flexibility: the relaxed complex scheme. J. Am. Chem. Soc 2002, 124(20):5632-5633. 10.1021/ja0260162, 12010024.
13. Alonso H, Bliznyuk AA, Gready JE. Combining docking and molecular dynamic simulations in drug design. Med. Res. Rev 2006, 26(5):531-568. 10.1002/med.20067, 16758486.
14. Amaro RE, Baron R, McCammon JA. An improved relaxed complex scheme for receptor flexibility in computer-aided drug design. J Comput Aided Mol Des 2008, 22(9):693-705. 10.1007/s10822-007-9159-2, 2516539, 18196463.
15. B-Rao C, Subramanian J, Sharma SD. Managing protein flexibility in docking and its applications. Drug Discov Today 2009, 14(7-8):394-400. 10.1016/j.drudis.2009.01.003, 19185058.
16. Huang Z, Wong CF. Conformational selection of protein kinase A revealed by flexible ligand flexible protein docking. J. Comput. Chem 2009, 30(4):631-644. 10.1002/jcc.21090, 18711718.
17. Wong CF. Flexible ligand-flexible protein docking in protein kinase systems. Biochim Biophys Acta 2008, 1784(1):244-251. 10.1016/j.bbapap.2007.10.005, 17996742.
18. Wei BQ, Weaver LH, Ferrari AM, Matthews BW, Shoichet BK. Testing a flexible-receptor docking algorithm in a model binding site. J. Mol. Biol 2004, 337(5):1161-1182. 10.1016/j.jmb.2004.02.015, 15046985.
19. Agüero F, Al-Lazikani B, Aslett M, Berriman M, Buckner FS, Campbell RK, Carmona S, Carruthers IM, Chan AW, Chen F, Crowther GJ, Doyle MA, Hertz-Fowler C, Hopkins AL, McAllister G, Nwaka S, Overington JP, Pain A, Paolini GV, Pieper U, Ralph SA, Riechers A, Roos DS, Sali A, Shanmugam D, Suzuki T, Van Voorhis WC, Verlinde CLMJ. Genomic-scale prioritization of drug targets: the TDR Targets database. Nat. Rev. Drug Discov 2008, 7(11):900-907. 10.1038/nrd2684, 3184002, 18927591.
20. Dessen A, Quemard A, Blanchard JS, Jacobs WR, Sacchettini JC. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 1995, 267(5204):1638. 10.1126/science.7886450, 7886450.
21. Schroeder EK, Basso LA, Santos DS, Norberto de Souza O. Molecular Dynamics Simulation Studies of the Wild-Type, I21V and I16T of Isoniazid_Resistant Mycobacterium tuberculosis Enoyl Reductase (InhA) in Complex with NADH: Towards the Understanding of NADH-InhA Different Affinities. Biophys J 2005, 89:876-884. 10.1529/biophysj.104.053512, 1366637, 15908576.
22. Basso LA, Zheng R, Musser JM, Jacobs WR, Blanchard JS. Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates. J. Infect.Dis 1998, 178:769-775. 10.1086/515362, 9728546.
23. Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ. The Amber biomolecular simulation programs. J. Comput. Chem 2005, 26(16):1668-1688. 10.1002/jcc.20290, 1989667, 16200636.
24. Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: applications of AutoDock. J. Mol. Recognit 1996, 9(1):1-5. 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6, 8723313.
25. Machado KS, Schroeder EK, Ruiz DD, Norberto de Souza O. Automating molecular docking with explicit receptor flexibility using scientific workflows. Lect. Notes Comput. Sc 4643:1-11.
26. Wang F, Langley R, Gulten G, Dover LG, Besra GS, Jacobs WR, Sacchettini JC. Mechanism of thioamide drug action against tuberculosis and leprosy. J. Exp. Med 2007, 204(1):73. 10.1084/jem.20062100, 2118422, 17227913.
27. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998, 394(6693):531-532. 10.1038/28970, 9707111.
28. Kuo MR, Morbidoni HR, Alland D, Sneddon SF, Gourlie BB, Staveski MM, Leonard M, Gregory JS, Janjigian AD, Yee C. Targeting tuberculosis and malaria through inhibition of enoyl reductase. J. Biol. Chem 2003, 278(23):20851. 10.1074/jbc.M211968200, 12606558.
29. Oliveira JS, Sousa EH, Basso LA, Palaci M, Dietze R, Santos DS, Moreira IS. An inorganic iron complex that inhibits wild-type and an isoniazid-resistant mutant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis. Chem Commun (Camb) 2004, (3):312-313.
30. Oliveira JS, de Sousa EH, de Souza ON, Moreira IS, Santos DS, Basso LA. Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex. Curr Pharm Des 2006, 12(19):2409-2424. 10.2174/138161206777698927, 16842188.
31. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996, 14(1):33-38, 27-28. 10.1016/0263-7855(96)00018-5, 8744570.
32. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem 1998, 19(14):1639-1662.
33. Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 1995, 8(2):127-134. 10.1093/protein/8.2.127, 7630882.
34. McCammon JA. Target flexibility in molecular recognition. Biochim Biophys Acta 2005, 1754(1-2):221-224. 10.1016/j.bbapap.2005.07.041, 16181817.
35. Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, Liang J. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 2006, 34:W116-W118. 10.1093/nar/gkl282, 1538779, 16844972.